We value your privacy

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies.

Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Perseus

MHRA – Is it safe and effective?

The Perseus Group is a multidisciplinary team of experts from various fields including medicine, pharmaceutical regulation and safety management.

The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for ensuring the safety and efficacy of medicines used in the UK. We have identified major failings in its safety management leading to serious safety issues with the Covid vaccines in particular but also medicines in general.

Our objective is to bring to this to the attention of politicians, policy makers and the media. Accordingly, we published a report in April 2023 and sent it to all MPs/Peers.

We received a Rule 9 request in October 2023 to provide written evidence to the Covid Inquiry (Module 4). Since then, the public hearings have been postponed until 2025. Of even greater concern is that the Inquiry announced on 22 May 2024 that it will not consider the safety and efficacy of the Covid vaccines; just the decision & approval process. The Perseus Group believes that it is not in the public interest to delay any further access to such expert evidence. We have therefore joined with other concerned groups to do make it public now here peoplesvaccineinquiry.co.uk

Questions for MHRA
See Main Report
Report Summary

Questions for MHRA

This is what MPs and the Media should be asking

Other Reports

We are working on other reports and evidence to the Covid Inquiry

Articles & Letters

We have written, and are aware of, some related articles and letters

References & Resources

We list some lesser known but very important references

“In the future, medicines, will come to market quicker with less data, with more research being conducted in the post-license phase.”

Sir Patrick Vallance (26 November 2014)
Read more

Want to know more?

Useful Links
First Name *
Last Name *
Email Address *
Contact Number
Message *